Changes in ghrelin and asymmetrical dimethylarginine in obese Mexican adolescents after six-month lifestyle intervention

Endocrine

Volumn 43, Issue 3, 2013, Pages 603-610

  Huang, Fengyang ^a   Del Río Navarro, Blanca Estela ^a   Pérez Ontiveros, José Alfredo ^a   Ruiz Bedolla, Eliseo ^a   Navarro Olivos, Efraín ^b   Villafaña, Santiago ^c   Bravo, Guadalupe ^c   Hong, Enrique ^c  

^a HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Asymmetrical dimethylarginine; Ghrelin; Lifestyle intervention; Obese adolescents

Indexed keywords

CHOLESTEROL; GHRELIN; GLUCOSE; INSULIN; N(G),N(G) DIMETHYLARGININE; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; OBESITY; PATIENT ASSESSMENT; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT; TREATMENT INDICATION; UPREGULATION; WEIGHT REDUCTION;

EID: 84877876243     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9808-7     Document Type: Article

References (43)

1. A.J. Van der Lely, M. Tschop, M.L. Heiman, E. Ghigo, Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr. Rev. 25, 426-457 (2004)
2. M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, K. Kangawa, Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656-660 (1999)
3. P. Wiedmer, R. Nogueiras, F. Broglio, D. D'Alessio, M.H. Tschop, Ghrelin, obesity and diabetes. Nat. Clin. Pract. Endocrinol. Metab. 3, 705-712 (2007)
4. M. Tschöp, C. Weyer, P.A. Tataranni, V. Devanarayan, E. Ravussin, M.L. Heiman, Circulating ghrelin levels are decreased in human obesity. Diabetes 50, 707-709 (2001)
5. A. Ikezaki, H. Hosoda, K. Ito, S. Iwama, N. Miura, H. Matsuoka, C. Kondo, M. Kojima, K. Kangawa, S. Sugihara, Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and adolescents. Diabetes 51, 3408-3411 (2002)
6. T. Shiiya, M. Nakazato, M. Mizuta, Y. Date, M.S. Mondal, M. Tanaka, S. Nozoe, H. Hosoda, K. Kangawa, S. Matsukura, Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J. Clin. Endocrinol. Metab. 87, 240-244 (2002)
7. R.S. Ahima, Ghrelin - a new player in glucose homeostasis? Cell Metab. 3, 301-302 (2006)
8. S. Bellone, N. Castellino, F. Broglio, A. Rapa, D. Vivenza, G. Radetti, J. Bellone, C. Gottero, E. Ghigo, G. Bona, Ghrelin secretion in childhood is refractory to the inhibiting effect of feeding. J. Clin. Endocrinol. Metab. 89, 1662-1665 (2004)
9. K.M. Choi, J. Lee, K.W. Lee, J.A. Seo, J.H. Oh, S.G. Kim, D.S. Choi, S.H. Baik, The associations between plasma adiponectin, ghrelin levels, and cardiovascular risk factors. Eur. J. Endocrinol. 150, 715-718 (2004)
10. L. Soriano-Guillen, V. Barrios, A. Campos-Barros, J. Argente, Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation. J. Pediatr. 144, 36-42 (2004)
11. T. Reinehr, C.L. Roth, U. Alexy, M. Kersting, W. Kiess, W. Andler, Ghrelin levels before and after reduction of overweight due to a low fat high carbohydrate diet in obese children and adolescents. Int. J. Obes. 29, 362-368 (2005)
12. D.G. Haider, K. Schindler, G. Prager, A. Bohdjalian, A. Luger, M. Wolzt, B. Ludvik, Serum retinol-binding protein-4 is reduced after weight loss in morbidly obese subjects. J. Clin. Endocrinol. Metab. 92, 1168-1171 (2007)
13. D.E. Cummings, D.S. Weigle, R.S. Frayo, P.A. Breen, M.K. Ma, E.P. Dellinger, J.Q. Purnell, Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N. Engl. J. Med. 346, 1623-1630 (2002)
14. T. Reinehr, G. de Sousa, L.R. Christian, Obestatin and ghrelin levels in obese children and adolescents before and after reduction of overweight. Clin. Endocrinol. 68, 304-310 (2008)
15. J.M. Garcia, D. Iyer, W.C.S. Posten, M. Marcelli, R. Reeves, J. Foreyt, A. Balasubramanyam, Rise of plasma ghrelin with weight loss is not sustained during weight maintenance. Obesity 14, 1716-1723 (2006)
16. D.S. Weigle, D.E. Cummings, P.D. Newby, P.A. Breen, R.S. Frayo, C.C. Matthys, H.S. Callahan, J. Purnell, Roles of leptin and ghrelin in the loss of body weight caused by a low fat, high carbohydrate diet. J. Clin. Endocrinol. Metab. 88, 1577-1586 (2003)
17. R.H. Böger, S.M. Bode-Böger, A. Szuba, P.S. Tsao, J.R. Chan, O. Tangphao, T.F. Blaschke, J.P. Cooke, Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 98, 1842-1847 (1998)
18. H. Matsuoka, S. Itoh, M. Kimoto, K. Kohno, O. Tamai, Y. Wada, H. Yasukawa, G. Iwami, S. Okuda, T. Imaizumi, Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension. Hypertension 29, 242-247 (1997)
19. R.H. Böger, S.M. Bode-Böger, W. Thiele, W. Junker, K. Alexander, J.C. Frolich, Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 95, 2068-2074 (1997)
20. F. Abbasi, T. Asagmi, J.P. Cooke, C. Lamendola, T. McLaughlin, G.M. Reaven, M. Stuehlinger, P.S. Tsao, Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus. Am. J. Cardiol. 88, 1201-1203 (2001)
21. C.D. Goonasekera, D.D. Rees, P. Woolar, Nitric oxide synthase inhibitors and hypertension in children and adolescents. J. Hypertens. 15, 901-909 (1997)
22. C.D. Goonasekera, V. Shah, D.D. Rees, M.J. Dillon, Nitric oxide activity in childhood hypertension. Arch. Dis. Child. 77, 11-16 (1997)
23. N. Nagaya, M. Kojima, M. Uematsu, Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, R1483-R1487 (2001)
24. R.J. Kuczmarski, C.L. Ogden, L.M. Grummer-Strawn, K.M. Flegal, S.S. Guo, R. Wei, Z. Mei, L.R. Curtin, A.F. Roche, C.L. Johnson, CDC growth charts: United States. Adv. Data 314, 1-28 (2000)
25. B. García-Cuartero, C. García-Lacalle, C. Jiménez-Lobo, A. González-Vergaz, C. Calvo-Rey, M.J. Alcázar-Villar, E. Díaz-Martínez, Indice HOMA y QUICKI, insulina y peptido C en ninos sanos. Puntos de corte de riesgo cardiovascular. An. Pediatr. (Barc) 66, 481-490 (2007)
26. R.K. Golley, A.M. Magarey, L.A. Baur, K.S. Steinbeck, L.A. Daniels, Twelve-month effectiveness of a parent-family-focused weight-management program for prepubertal children: a randomized controlled trial. Pediatrics 119, 517-525 (2007)
27. F.Y. Huang, B. Del-Río-Navarro, G. Toussaint Martínez de Castro, S. Torres-Alcántara, J.J.J. Siera-Monge, J.A. Pérez-Ontiveros, E. Navarro-Olivos, M. Figueroa-Barron, A. Reyes-Lopéz, S. Villafaña, E. Hong, Weight loss induced by 6-month lifestyle intervention improves early endothelial activation and fibrinolysis in obese adolescents. Child Care Health. Dev. 37, 377-384 (2011)
28. C. Pedrosa, B.M.P.M. Oliveira, I. Albuquerque, C. Simões-Pereira, M.D. Vaz-de-Almeida, F. Correia, Metabolic syndrome, adipokines and ghrelin in overweight and obese schoolchildren: results of a 1-year lifestyle intervention programme. Eur. J. Pediatr. 170, 483-492 (2011)
29. M.P. Bahíllo-Curieses, F. Hermoso-López, M.J. Martínez-Sopena, P. Cobreros-García, P. García-Saseta, M. Tríguez-García, J.M. Marugán-Miguelsanz, Prevalence of insulin resistance and impaired glucose tolerance in a sample of obese Spanish children and adolescents. Endocrine 41, 289-295 (2012)
30. C. Gazzaruso, S. Giordanetti, A. La Manna, M. Celsa, E. De Amici, C. Turpini, A. Catona, P. Fratino, Weight loss after Swedish Adjustable Gastric Banding: relationships to insulin resistance and metabolic syndrome. Obes. Surg. 12, 841-845 (2002)
31. L. Velázquez-López, E. González-Figueroa, P. Medina-Bravo, I. Pineda-del Aguila, L. Ávila-Jiménez, R. Ramos-Hernández, M. Klunder-Klunder, J. Escobedo-de la Peña, Low calorie and carbohydrate diet: to improve the cardiovascular risk indicators in overweight or obese adults with prediabetes. Endocrine (2012). doi: 10.1007/s12020-012-9775-z
32. P. Balagopal, S.S. Gidding, L.M. Buckloh, H.N. Yarandi, J.E. Sylvester, D.E. George, V.L. Funanage, Changes in circulating satiety hormones in obese children: a randomized controlled physical activity-based intervention study. Obesity 18, 1747-1753 (2010)
33. R. Kelishadi, M. Hashemipour, N. Mohammadifard, H. Alikhassy, K. Adeli, Short- and long-term relationships of serum ghrelin with changes in body composition and the metabolic syndrome in prepubescent obese children following two different weight loss programmes. Clin. Endocrinol. 69, 721-729 (2008)
34. A.C. Ellis, P. Chandler-Laney, K. Casazza, L.L. Goree, B.A. Gower, Effects of habitual diet on ethnic differences in serum total ghrelin. Endocrine (2012). doi: 10.1007/s12020-012-9667-2
35. H.J. Leidy, J.K. Gardner, B.R. Frye, M.L. Snook, M.K. Schuchert, E.L. Richard, N.I. Williams, Circulating ghrelin is sensitive to changes in body weight during a diet and exercise program in normal-weight young women. J. Clin. Endocrinol. Metab. 89, 2659-2664 (2004)
36. F. Bacha, S.A. Arslanian, Ghrelin suppression in overweight children: a manifestation of insulin resistance? J. Clin. Endocrinol. Metab. 90, 2725-2730 (2005)
37. T. McLaughlin, F. Abbasi, C. Lamendola, R.S. Frayo, D.E. Cummings, Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls. J. Clin. Endocrinol. Metab. 89, 1630-1635 (2004)
38. R. Barazzoni, M. Zanetti, C. Ferreira, Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome. J. Clin. Endocrinol. Metab. 92, 3935-3940 (2007)
39. H.J. Kim, S. Lee, T.W. Kim, Effects of exercise-induced weight loss on acylated and unacylated ghrelin in overweight children. Clin. Endocrinol. (Oxf) 68, 416-422 (2008)
40. H.-J. Gruber, C. Mayer, A. Meinitzer, G. Almer, R. Horejsi, R. Möller, S. Pilz, W. März, R. Gasser, M. Truschnig-Wilders, H. Mangge, Asymmetric dimethylarginine (ADMA) is tightly correlated with growth in juveniles without correlations to obesity related disorders. Exp. Clin. Endocrinol. Diabetes 116, 520-524 (2008)
41. G. Rudofsky, E. Roeder, T. Merle, M. Hildebrand, P.P. Nawroth, C. Wolfrum, Weight loss improves endothelial function independently of ADMA reduction in severe obesity. Horm. Metab. Res. 43, 343-348 (2011)
42. K. Krzyzanowska, F. Mittermayer, H.-P. Kopp, M. Wolzt, G. Schernthaner, Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese women. J. Clin. Endocrinol. Metab. 89, 6277-6281 (2004)
43. T. McLaughlin, M. Stühlinger, C. Lamendola, F. Abbasi, J. Bialek, G.M. Reaven, P.S. Tsao, Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss. J. Clin. Endocrinol. Metab. 91, 1896-1900 (2006)